FDA Import Refusal SCS-6582303-3/11/1 — LAZARIO GROUP LIMITED
The FDA refused shipment SCS-6582303-3/11/1 from LAZARIO GROUP LIMITED (Hong Kong) on Aug 13, 2021. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Aug 13, 2021
- Country
- Hong Kong
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75